A study by LV Prasad Eye Institute highlights rising antimicrobial resistance in post-cataract infections, with aggressive Gram-negative bacteria resisting standard antibiotics. Nearly 8% of cases are multidrug-resistant, forcing use of last-resort drugs like Colistin, yet vision recovery remains poor
